SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of SU5416 in treating patients who have advanced,
metastatic, or recurrent soft tissue sarcomas. SU5416 may stop the growth of soft tissue
sarcomas by stopping blood flow to the tumor.